Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatrist.com
Treatment preferences shifted to include nonaugmentative antidepressants and electroconvulsive therapy based on changes in patient characteristics.
Psychiatry February 4th 2026
Psych Congress Network
Clozapine did not show superior efficacy compared to second-generation antipsychotics in treatment-resistant schizophrenia.
Clinical Pharmacology May 28th 2025
Schizophrenia Bulletin
Co-commencing metformin with antipsychotics can reduce weight gain by over 4 kg compared to controls, providing a concrete strategy for managing one of psychiatry’s most challenging side effects.
Endocrinology, Diabetes, Metabolism January 8th 2025
Psych Congress NP Institute
Expert psychiatric nurse practitioners stress the importance of familiarity with product inserts for each long-acting injectable antipsychotic to effectively manage missed doses in schizophrenia treatment.
Neurology August 27th 2024
Psychiatry Advisor
Erzofri offers a new once-monthly injectable option for treating schizophrenia and schizoaffective disorder, potentially improving medication adherence for some patients.
Geriatrics August 27th 2024
Epoch Health
Schizophrenia is a chronic brain disorder characterized by hallucinations, delusions, and cognitive impairments, affecting up to 1 percent of the global population. Understanding its symptoms, causes, and treatment options is crucial for effective patient care.
Psychiatry July 3rd 2024